JP2015508780A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508780A5 JP2015508780A5 JP2014557870A JP2014557870A JP2015508780A5 JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5 JP 2014557870 A JP2014557870 A JP 2014557870A JP 2014557870 A JP2014557870 A JP 2014557870A JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- composition
- administering
- immunocompromised patients
- inhaler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010061598 Immunodeficiency Diseases 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 229940071648 Metered Dose Inhaler Drugs 0.000 claims 2
- 239000007922 nasal spray Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229940112141 Dry Powder Inhaler Drugs 0.000 claims 1
- 208000006572 Human Influenza Diseases 0.000 claims 1
- 206010022000 Influenza Diseases 0.000 claims 1
- 229940097496 Nasal Spray Drugs 0.000 claims 1
- 206010054979 Secondary immunodeficiency Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 238000002650 immunosuppressive therapy Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 201000002367 primary immunodeficiency disease Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
Claims (10)
- 免疫不全患者のパラインフルエンザ又はインフルエンザ感染を低減又は処置するために前記患者の気道に投与される医薬製造のための組成物の使用であって、前記組成物が治療有効量のタンパク質を含み、前記タンパク質が配列番号１又は２を含むことを特徴とする使用。
- 前記免疫不全患者には、原発性免疫不全症を患っている患者が含まれる、請求項１に記載の使用。
- 前記免疫不全患者には、続発性免疫不全症を患っている患者が含まれる、請求項１に記載の使用。
- 前記免疫不全患者には、免疫抑制療法で処置されている又はされたことがある患者が含まれる、請求項１に記載の使用。
- 前記免疫不全患者には、化学療法剤で処置されている又はされたことがある患者が含まれる、請求項１に記載の使用。
- 前記投与が、鼻腔スプレーの使用によるものである、請求項１に記載の使用。
- 前記投与が、吸入器の使用によるものである、請求項１に記載の使用。
- 前記投与が、ネブライザー、気化器、気管内チューブ、鼻腔スプレー、ドライパウダー吸入器、加圧噴霧式定量吸入器、又は呼吸作動式加圧噴霧式定量吸入器によるものである、請求項１に記載の使用。
- 前記組成物が液体の形態である、請求項１に記載の使用。
- 前記組成物がドライパウダーの形態である、請求項１に記載の使用。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600545P | 2012-02-17 | 2012-02-17 | |
| US61/600,545 | 2012-02-17 | ||
| US201261727627P | 2012-11-16 | 2012-11-16 | |
| US61/727,627 | 2012-11-16 | ||
| PCT/US2013/026754 WO2013123521A1 (en) | 2012-02-17 | 2013-02-19 | Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015508780A JP2015508780A (ja) | 2015-03-23 |
| JP2015508780A5 true JP2015508780A5 (ja) | 2016-04-21 |
Family
ID=48984833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557870A Pending JP2015508780A (ja) | 2012-02-17 | 2013-02-19 | 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20130280332A1 (ja) |
| EP (1) | EP2841092B1 (ja) |
| JP (1) | JP2015508780A (ja) |
| CN (2) | CN109529026A (ja) |
| AU (3) | AU2013221230A1 (ja) |
| CA (1) | CA2864746A1 (ja) |
| ES (1) | ES2970401T3 (ja) |
| HK (1) | HK1207975A1 (ja) |
| IL (2) | IL234116B (ja) |
| WO (1) | WO2013123521A1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6022442B2 (ja) | 2010-05-14 | 2016-11-09 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | 男性用避妊組成物および使用方法 |
| CA2799403C (en) | 2010-05-14 | 2020-01-21 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating leukemia |
| EP2571503B1 (en) | 2010-05-14 | 2015-01-07 | Dana-Farber Cancer Institute, Inc. | Compositions and their use in treating neoplasia, inflammatory disease and other disorders |
| AU2014292888B2 (en) | 2013-07-25 | 2018-03-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
| CN105849110B (zh) | 2013-11-08 | 2019-08-02 | 达纳-法伯癌症研究所有限公司 | 使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法 |
| EP3099693A4 (en) | 2014-01-31 | 2017-08-16 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| CA2936865A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
| SG11201607108XA (en) | 2014-02-28 | 2016-09-29 | Tensha Therapeutics Inc | Treatment of conditions associated with hyperinsulinaemia |
| CA2955074A1 (en) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| CN106793775B (zh) | 2014-08-08 | 2020-06-02 | 达纳-法伯癌症研究所股份有限公司 | 二氢碟啶酮衍生物及其用途 |
| UA122130C2 (uk) | 2014-10-27 | 2020-09-25 | Тенша Терапеутікс, Інк. | Інгібітори бромодомену |
| WO2016073903A1 (en) * | 2014-11-06 | 2016-05-12 | Dana-Farber Cancer Institute, Inc. | Use of compositions modulating chromatin structure for graft versus host disease (gvhd) |
| EP3885343A1 (en) | 2014-11-06 | 2021-09-29 | Dana-Farber Cancer Institute, Inc. | Indole compounds as ezh2 inhibitors and uses thereof |
| US20180177852A1 (en) * | 2015-06-08 | 2018-06-28 | Ansun Biopharma, Inc. | Treatment of human metapneumovirus |
| WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| CN108472299A (zh) | 2015-09-11 | 2018-08-31 | 达纳-法伯癌症研究所股份有限公司 | 乙酰胺噻吩并三唑并二氮杂环庚三烯及其用途 |
| KR20180049058A (ko) | 2015-09-11 | 2018-05-10 | 다나-파버 캔서 인스티튜트 인크. | 시아노 티에노트리아졸로디아제핀 및 그의 용도 |
| SG11201803210YA (en) | 2015-11-25 | 2018-05-30 | Dana Farber Cancer Inst Inc | Bivalent bromodomain inhibitors and uses thereof |
| EP3445365A4 (en) | 2016-04-22 | 2019-10-16 | Dana-Farber Cancer Institute, Inc. | EZH2 INHIBITORS AND USES THEREOF |
| CN115297874A (zh) * | 2019-11-25 | 2022-11-04 | 安迅生物制药公司 | 唾液酸酶至癌细胞、免疫细胞和肿瘤微环境的免疫细胞递送 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8245708B2 (en) * | 2002-05-07 | 2012-08-21 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
| CN1700934B (zh) * | 2002-09-06 | 2011-08-03 | 菲利普莫里斯美国公司 | 液体气溶胶制剂和用于制备气溶胶的气溶胶产生装置及方法 |
| KR20050085130A (ko) | 2002-11-22 | 2005-08-29 | 유 망 | 광범위 스펙트럼의 항-바이러스 치료제 및 예방제 |
| US7807174B2 (en) | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| RU2464973C2 (ru) | 2006-01-24 | 2012-10-27 | НексБио, Инк. | Технология изготовления макромолекулярных микросфер |
| CN102711807A (zh) * | 2009-11-06 | 2012-10-03 | 耐百生物制药有限公司 | 用于在呼吸道中进行治疗和预防的方法、化合物和组合物 |
-
2013
- 2013-02-19 CN CN201811368987.7A patent/CN109529026A/zh active Pending
- 2013-02-19 EP EP13749329.2A patent/EP2841092B1/en active Active
- 2013-02-19 CA CA2864746A patent/CA2864746A1/en not_active Abandoned
- 2013-02-19 US US13/770,991 patent/US20130280332A1/en not_active Abandoned
- 2013-02-19 CN CN201380009763.6A patent/CN104203267A/zh active Pending
- 2013-02-19 JP JP2014557870A patent/JP2015508780A/ja active Pending
- 2013-02-19 WO PCT/US2013/026754 patent/WO2013123521A1/en active Application Filing
- 2013-02-19 AU AU2013221230A patent/AU2013221230A1/en not_active Abandoned
- 2013-02-19 ES ES13749329T patent/ES2970401T3/es active Active
-
2014
- 2014-08-13 IL IL234116A patent/IL234116B/en active IP Right Grant
-
2015
- 2015-01-26 US US14/605,572 patent/US20150132274A1/en not_active Abandoned
- 2015-09-04 HK HK15108646.4A patent/HK1207975A1/xx unknown
-
2017
- 2017-02-10 US US15/430,288 patent/US20170151315A1/en not_active Abandoned
- 2017-11-10 AU AU2017258955A patent/AU2017258955A1/en not_active Abandoned
-
2019
- 2019-09-05 AU AU2019226190A patent/AU2019226190B2/en not_active Ceased
-
2020
- 2020-03-10 IL IL273194A patent/IL273194B2/en unknown
- 2020-07-31 US US16/945,776 patent/US20210046165A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508780A5 (ja) | ||
| IL273194B2 (en) | Methods, compounds and preparations for the treatment of parainfluenza virus in patients with a deficiency in the immune system | |
| BR112013028572B8 (pt) | Bocais para distribuição de droga nasal | |
| Harb et al. | Is Combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? | |
| CN204502085U (zh) | 呼吸内科用喷药器 | |
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| JP2013224331A5 (ja) | ||
| JP2014528470A5 (ja) | ||
| JP2014530231A5 (ja) | ||
| MX2021012723A (es) | Inhalador de presión positiva para entrega de medicamento inhalable y métodos para uso. | |
| PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
| WO2012047182A3 (en) | Single dose dry powder inhalation device | |
| EA202091199A1 (ru) | Лекарственное средство для предотвращения или лечения риновирусной инфекции | |
| MX2021006585A (es) | Ciclosporina a en forma solubilizada en liposomas (l-csa) para usarse en el tratamiento de enfermedades pulmonares mediante la inhalación de un aerosol generado por un nebulizador. | |
| CN204092782U (zh) | 一种医用雾化器 | |
| NZ600208A (en) | Inhalation solutions | |
| JP2013522295A5 (ja) | ||
| MX2020010977A (es) | Procedimientos de tratamiento de infecciones fúngicas. | |
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| BR112013020632A8 (pt) | Composição farmacêutica para a administração tópica | |
| EA201201394A1 (ru) | Ингалятор для доставки лекарственного средства в виде сухого порошка | |
| EP4005565A1 (en) | Novel uses of adamantane derivatives | |
| CN203436639U (zh) | 一种雾化器 | |
| CN204601325U (zh) | 一种药液雾化吸雾面罩 | |
| CN203634594U (zh) | 带有眼罩的雾化器 |